What they were paid
Bicara Therapeutics Director Compensation Table · the one fiscal year held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $44,000 | — | $208,634 | — | $252,634 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Bicara Therapeutics Inc. DEF 14A filed April 27, 2026, accession 0001628280-26-027320, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2025Bicara Therapeutics pays directors a $40,000 cash retainer and $47,492 in Options.
The rest of the Bicara Therapeutics board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Carolyn Ng | Independent Director | $0 |
| Christopher Bowden | Independent Director | $253,634 |
| Jake Simson | Independent Director | $252,634 |
| Kate Haviland | Independent Director | $253,634 |
| Michael Powell | Independent Director | $296,134 |
| Nils Lonberg | Independent Director | $256,634 |
| Scott Robertson | Independent Director | $263,634 |
The full Bicara Therapeutics compensation record
free company briefThis page is one director within Bicara Therapeutics's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat